{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:08:22Z","timestamp":1790183302284,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013187","name":"Randy Shaver Cancer Research & Community Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["5K08 CA255426-03"],"award-info":[{"award-number":["5K08 CA255426-03"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Immunology & Cellular Therapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bict.2026.100069","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:30:36Z","timestamp":1782401436000},"page":"100069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["B7-H3 expression affects outcomes in myeloma and is targetable with an NK cell engager"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4433-0127","authenticated-orcid":false,"given":"Aimee M.","family":"Merino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"Grzywacz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayden","family":"Hamsher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5074-9564","authenticated-orcid":false,"given":"Young","family":"Vue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7305-0565","authenticated-orcid":false,"given":"Hazel","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8305-1867","authenticated-orcid":false,"given":"Benjamin","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Krhovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Forster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3197-5885","authenticated-orcid":false,"given":"Laura","family":"Bendzick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0240-0123","authenticated-orcid":false,"given":"Megan","family":"Weivoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8653-4921","authenticated-orcid":false,"given":"Neha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1832-7956","authenticated-orcid":false,"given":"Anders","family":"Narum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Shanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Felices","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7021-968X","authenticated-orcid":false,"given":"Nicholas A.","family":"Zorko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5307-6648","authenticated-orcid":false,"given":"Evren","family":"Alici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.bict.2026.100069_bib1","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood.2024026455","article-title":"The bone marrow NK-cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy","volume":"145","author":"Korst","year":"2025","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bict.2026.100069_bib2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/bjh.19049","article-title":"Tumour-derived exosomes promote the induction of monocytic myeloid-derived suppressor cells from peripheral blood mononuclear cells by delivering miR-106a-5p and miR-146a-5p in multiple myeloma","volume":"203","author":"Mizuhara","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bict.2026.100069_bib3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.canlet.2018.11.002","article-title":"Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway","volume":"442","author":"De Veirman","year":"2019","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bict.2026.100069_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.684561","article-title":"Mechanisms of action of the new antibodies in use in multiple myeloma","volume":"11","author":"Romano","year":"2021","journal-title":"Front Oncol"},{"issue":"23","key":"10.1016\/j.bict.2026.100069_bib5","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1182\/bloodadvances.2017006866","article-title":"Effects of daratumumab on natural killer cells and impact on clinical outcomes in relapsed or refractory multiple myeloma","volume":"1","author":"Casneuf","year":"2017","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.bict.2026.100069_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/imr.12521","article-title":"The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3","volume":"276","author":"Janakiram","year":"2017","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.bict.2026.100069_bib7","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/s41375-018-0331-6","article-title":"B7-H3 promotes multiple myeloma cell survival and proliferation by ROS-dependent activation of Src\/STAT3 and c-Cbl-mediated degradation of SOCS3","volume":"33","author":"Lin","year":"2019","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.bict.2026.100069_bib8","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.3390\/cancers12092659","article-title":"NK-cell-mediated targeting of various solid tumors using a B7-H3 tri-specific killer engager in vitro and in vivo","volume":"12","author":"Vallera","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"34","key":"10.1016\/j.bict.2026.100069_bib9","doi-asserted-by":"crossref","first-page":"12640","DOI":"10.1073\/pnas.0405025101","article-title":"Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis","volume":"101","author":"Castriconi","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.bict.2026.100069_bib10","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.str.2013.03.003","article-title":"Structure and T cell inhibition properties of B7 family member, B7-H3","volume":"21","author":"Vigdorovich","year":"2013","journal-title":"Structure"},{"issue":"8","key":"10.1016\/j.bict.2026.100069_bib11","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1158\/0008-5472.CAN-15-1538","article-title":"Immunoregulatory protein B7-H3 reprograms glucose metabolism in cancer cells by ROS-mediated stabilization of HIF1\u03b1","volume":"76","author":"Lim","year":"2016","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.bict.2026.100069_bib12","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.bbrc.2016.12.021","article-title":"B7-H3 regulates lipid metabolism of lung cancer through SREBP1-mediated expression of FASN","volume":"482","author":"Luo","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.bict.2026.100069_bib13","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.4049\/jimmunol.172.4.2352","article-title":"Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains","volume":"172","author":"Steinberger","year":"2004","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.bict.2026.100069_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13045-025-01756-5","article-title":"B7-H3 nanobody-based CAR T cells control multiple myeloma growth, while dual BCMA\/B7-H3 CAR T cells overcome antigen escape","volume":"18","author":"Van der Vreken","year":"2025","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.bict.2026.100069_bib15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41419-020-2252-3","article-title":"B7-H3 promotes colorectal cancer angiogenesis through activating the NF-kB pathway to induce VEGFA expression","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.bict.2026.100069_bib16","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.3389\/fonc.2019.01466","article-title":"Overexpression of B7-H3 in \u03b1-SMA-positive fibroblasts is associated with cancer progression and survival in gastric adenocarcinomas","volume":"9","author":"Zhan","year":"2019","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.bict.2026.100069_bib17","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/bjh.14493","article-title":"Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1","volume":"176","author":"Bar-Natan","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bict.2026.100069_bib18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejca.2020.03.033","article-title":"Effects of B7-H3 expression on tumour-infiltrating immune cells and clinicopathological characteristics in non-small-cell lung cancer","volume":"133","author":"Yim","year":"2020","journal-title":"Eur J Cancer"},{"issue":"15","key":"10.1016\/j.bict.2026.100069_bib19","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1158\/0008-5472.CAN-13-0305","article-title":"Myeloid-derived suppressor cells as a novel target for control of osteolytic bone disease","volume":"73","author":"Sawant","year":"2013","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.bict.2026.100069_bib20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4049\/jimmunol.182.1.240","article-title":"Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-\u03b21","volume":"182","author":"Li","year":"2009","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.bict.2026.100069_bib21","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41419-021-04275-6","article-title":"B7-H3 regulates osteoclast differentiation via type I interferon-dependent IDO induction","volume":"12","author":"Oh","year":"2021","journal-title":"Cell Death Dis"},{"issue":"7","key":"10.1016\/j.bict.2026.100069_bib22","doi-asserted-by":"crossref","first-page":"e011370","DOI":"10.1136\/jitc-2024-011370","article-title":"Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancer","volume":"13","author":"Khaw","year":"2025","journal-title":"J Immunother Cancer"},{"issue":"4","key":"10.1016\/j.bict.2026.100069_bib23","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.mayocp.2013.01.019","article-title":"Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013","volume":"88","author":"Mikhael","year":"2013","journal-title":"Mayo Clin Proc"},{"issue":"15","key":"10.1016\/j.bict.2026.100069_bib24","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International Staging System for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J Clin Oncol"},{"issue":"6074","key":"10.1016\/j.bict.2026.100069_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.1.6074.1473-a","article-title":"Correcting the calcium","volume":"1","author":"Phillips","year":"1977","journal-title":"Br Med J"},{"issue":"4","key":"10.1016\/j.bict.2026.100069_bib26","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.4049\/jimmunol.1000901","article-title":"Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells","volume":"185","author":"Lechner","year":"2010","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.bict.2026.100069_bib27","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1182\/blood-2018-01-828343","article-title":"Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL","volume":"132","author":"Rossi","year":"2018","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.bict.2026.100069_bib28","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1182\/bloodadvances.2024013195","article-title":"Analysis of polyfunctionality for enhanced BAFF-R CAR T-cell therapy for hematologic malignancies","volume":"8","author":"Dong","year":"2024","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.bict.2026.100069_bib29","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.4161\/onci.21990","article-title":"Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction","volume":"1","author":"Danilin","year":"2012","journal-title":"Oncoimmunology"},{"issue":"2","key":"10.1016\/j.bict.2026.100069_bib30","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1158\/0008-5472.CAN-12-2202","article-title":"Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer","volume":"73","author":"Sawant","year":"2013","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.bict.2026.100069_bib31","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.4049\/jimmunol.180.3.1545","article-title":"Bone marrow stroma confers resistance to Apo2 ligand\/TRAIL in multiple myeloma in part by regulating c-FLIP","volume":"180","author":"Perez","year":"2008","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.bict.2026.100069_bib32","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1038\/s41467-024-47793-5","article-title":"Bone marrow stromal cells induce chromatin remodeling in multiple myeloma cells leading to transcriptional changes","volume":"15","author":"Binder","year":"2024","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.bict.2026.100069_bib33","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1038\/bjc.2014.113","article-title":"Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c","volume":"110","author":"Nygren","year":"2014","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.bict.2026.100069_bib34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41420-021-00527-8","article-title":"MicroRNA-326 attenuates immune escape and prevents metastasis in lung adenocarcinoma by targeting PD-L1 and B7-H3","volume":"7","author":"Shao","year":"2021","journal-title":"Cell Death Discov"},{"issue":"5","key":"10.1016\/j.bict.2026.100069_bib35","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/leu.2010.62","article-title":"Prognostic variables for survival and skeletal complications in patients with multiple myeloma osteolytic bone disease","volume":"24","author":"Terpos","year":"2010","journal-title":"Leukemia"},{"issue":"23","key":"10.1016\/j.bict.2026.100069_bib36","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.3390\/cancers15235562","article-title":"Circulating sRANKL, periostin, and osteopontin as biomarkers for the assessment of activated osteoclastogenesis in myeloma related bone disease","volume":"15","author":"Gerov","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.bict.2026.100069_bib37","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1182\/blood.V63.2.468.468","article-title":"Beta-2-microglobulin in myeloma: optimal use for staging, prognosis, and treatment--a prospective study of 160 patients","volume":"63","author":"Bataille","year":"1984","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bict.2026.100069_bib38","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1182\/blood.2023023529","article-title":"NK cells with adhesion defects and reduced cytotoxic functions are associated with a poor prognosis in multiple myeloma","volume":"144","author":"Blanquart","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.bict.2026.100069_bib39","doi-asserted-by":"crossref","DOI":"10.1136\/jclinpath-2016-203614","article-title":"Decreased CD161 activating and increased CD158a inhibitory receptor expression on NK cells underlies impaired NK cell cytotoxicity in patients with multiple myeloma","author":"Konjevic","year":"2016","journal-title":"J Clin Pathol"},{"issue":"5","key":"10.1016\/j.bict.2026.100069_bib40","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/ijc.29087","article-title":"Human natural killer cells promote cross-presentation of tumor cell-derived antigens by dendritic cells","volume":"136","author":"Deauvieau","year":"2015","journal-title":"Int J Cancer"},{"issue":"26","key":"10.1016\/j.bict.2026.100069_bib41","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1182\/blood.2021012811","article-title":"Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma","volume":"139","author":"Sakemura","year":"2022","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.bict.2026.100069_bib42","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1182\/blood-2012-08-448548","article-title":"Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans","volume":"121","author":"Gorgun","year":"2013","journal-title":"Blood"}],"container-title":["Blood Immunology & Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050597626000394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050597626000394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:32:19Z","timestamp":1790181139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050597626000394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S3050597626000394"],"URL":"https:\/\/doi.org\/10.1016\/j.bict.2026.100069","relation":{},"ISSN":["3050-5976"],"issn-type":[{"value":"3050-5976","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B7-H3 expression affects outcomes in myeloma and is targetable with an NK cell engager","name":"articletitle","label":"Article Title"},{"value":"Blood Immunology & Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bict.2026.100069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100069"}}